Ivermectin B1a
Ivermectin B1a is the principal component of commercial ivermectin, derived from Avermectin B1a. It is widely used in research to study antiparasitic mechanisms and modulate glutamate-gated chloride channels in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
71827-03-7
Product Name Alternative
COVID-19, Avermectin, B1a, anti-parasite, Parasite, Ivermectin, Ivermectin B1a, inhibit, Inhibitor, SARS-CoV, SARSCoV, SARS coronavirus, SARS-CoV-2
Field of Research
Infectious Disease & Virology
Purity
96.18% (May vary between batches)
Solubility
DMSO:100 mg/mL (114.27 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (4.57 mM)
Smiles
CC[C@H] (C) [C@@H]1[C@H] (CC[C@@]2 (O1) C[C@@H]3C[C@H] (O2) C/C=C (/[C@H] ([C@H] (/C=C/C=C/4\CO[C@H]5[C@@]4 ([C@@H] (C=C ([C@H]5O) C) C (=O) O3) O) C) O[C@H]6C[C@@H] ([C@H] ([C@@H] (O6) C) O[C@H]7C[C@@H] ([C@H] ([C@@H] (O7) C) O) OC) OC) \C) C
Molecular Formula
C48H74O14
Molecular Weight
875.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog